[go: up one dir, main page]

EP3718505A1 - Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux - Google Patents

Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux Download PDF

Info

Publication number
EP3718505A1
EP3718505A1 EP19167599.0A EP19167599A EP3718505A1 EP 3718505 A1 EP3718505 A1 EP 3718505A1 EP 19167599 A EP19167599 A EP 19167599A EP 3718505 A1 EP3718505 A1 EP 3718505A1
Authority
EP
European Patent Office
Prior art keywords
distal
filter
funnel
main body
proximal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19167599.0A
Other languages
German (de)
English (en)
Inventor
Francesco Bonetti
Stefano OSTA
Enrico Pasquino
Franco OSTA
Yi Peng BAI
Giulia PARIGI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aorticlab Sarl
Original Assignee
Aorticlab Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66101957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP3718505(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aorticlab Sarl filed Critical Aorticlab Sarl
Priority to EP19167599.0A priority Critical patent/EP3718505A1/fr
Priority to CN202080027045.1A priority patent/CN113660915B/zh
Priority to CA3130859A priority patent/CA3130859A1/fr
Priority to JP2021557526A priority patent/JP7485383B2/ja
Priority to US17/442,168 priority patent/US12465477B2/en
Priority to PCT/EP2020/059601 priority patent/WO2020201524A1/fr
Priority to EP20720905.7A priority patent/EP3946146B1/fr
Publication of EP3718505A1 publication Critical patent/EP3718505A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01—Filters implantable into blood vessels
    • A61F2/0105—Open ended, i.e. legs gathered only at one side
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01—Filters implantable into blood vessels
    • A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01—Filters implantable into blood vessels
    • A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
    • A61F2002/015—Stop means therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01—Filters implantable into blood vessels
    • A61F2002/016—Filters implantable into blood vessels made from wire-like elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • A61F2002/9511—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9534—Instruments specially adapted for placement or removal of stents or stent-grafts for repositioning of stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063—Three-dimensional shapes
    • A61F2230/0067—Three-dimensional shapes conical

Definitions

  • the present invention generally relates to a transcatheter anti embolic filter, in particular to an intra-aortic filter to be used to protect cerebral and peripheral vessels from potential dissemination of emboli.
  • TAVI transcatheter heart valve prosthesis
  • the procedural embolic events are occurring during a TAVI implant procedure (during predilation, implant or postdilation) and are mainly related to the embolization of macro debris of calcium of fibroelatic particles usually targeting the brain (strokes), the coronary arteries or the peripheral organs.
  • the strokes are the most frightful clinical events occurring, nowadays, at a rate of 2.7% against a rate of 3.3% of the previous generations of TAVIs.
  • This reduction of strokes is related to the minor need of pre- and postdilation during TAVI implant nevertheless this data are unclear since are referring to aortic valves with a mild level of calcification.
  • the post-procedural micro-embolic cerebral events are documented in at least 8% of the patients submitted to investigation. The high incidence of new cerebral lesions after TAVI warrants for a longer term evaluation of neurocognitive function.
  • Future research in the field of TAVI should thus be directed at developing strategies to reduce the risk of embolization (e.g., less traumatic, smaller-bore catheter systems, improved identification of patients at risk for embolization and a potential use of cerebral protection devices).
  • embolization e.g., less traumatic, smaller-bore catheter systems, improved identification of patients at risk for embolization and a potential use of cerebral protection devices.
  • embolic events are the sub-acute and chronic microembolic events occurring after the immediate post-procedural time.
  • the native aortic calcific valve is rough, with a warty surface, immobilized acting like an atherosclerotic ulcerated plaque. This condition is favouring the formation of microtrombi that later-on embolize towards the brain and other peripheral organs.
  • the native aortic valve left in place as a source of microemboli has been taken into account in several clinical studies that demonstrated their role in the onset of vascular origin dementia. This evidence creates a concern when the TAVI are implanted in younger patients where an acceleration of the vascular dementia could impact in a serious way on the social costs.
  • the periprocedural clinical complications following a TAVI implant are strongly related to the presence of the heavily calcified aortic valve left in place. It brings, acutely, an occurrence of macro-embolic cerebral events (strokes) and hemodynamic consequences such as the PVLs resulting in a various severity of aortic valve insufficiency.
  • strokes macro-embolic cerebral events
  • PVLs vascular valve insufficiency
  • These unsatisfactory clinical outcomes are closely related to an irregular deployment of the transcatheter valve prostheses in concomitance of highly calcified aortic native valves.
  • the longer term clinical complications are characterized by the cerebral micro-embolizations generated by the native aortic valve leaflets' left in place that become a source of emboli responsible for vascular dementia.
  • the overall rate of clinical complications in TAVI is ranging between 5% and 12%. This occurrence is most probably underestimated because it does not include patients with highly calcified and biscuspid native valves.
  • AKI acute Kidney Injury
  • TAVI Treatment Kidney Injury
  • TAVI procedures apply also to other transcatheter procedures, such as valvuloplasty (when unassociated to TAVI), native valve repair and heart recovery procedures, all conditions potentially leading to emboli release from ventricle, native valve or thoracic aorta.
  • catheter navigation itself along a calcified aorta can make calcification dislodgement and emboli release.
  • Patents Application including emboli protection were filed since 20 years ago, such as the invention disclosed in US 6,361,545 , disclosing a perfusion filter catheter able to be adopted in the frame of SAVR and cardiopulmonary bypass procedures and AU 2011202667 , disclosing and embolic filter apparatus and method for heart valve replacement.
  • the deflector devices deflect emboli from the brachiocephalic trunk and the left common carotid artery towards the peripheral circulation: therefore, they only impede debris entering in the cerebral vessels and diverting them to the peripheral circulation. Moreover, in case of dislodgement from their intended position, the diverting function is missed.
  • the antiembolic filter on the market whose main characteristics are disclosed in United States Patent Application Publication US 2018177582 , actually captures emboli with a mesh, but only cover two of the three cerebral vessels and not the peripheral circulation.
  • United States Patent Application Publication US 2018/0110607 discloses an embolic protection device filter which is able to protect the cerebral and systemic circulation; the device has a collection chamber for emboli captured containment, and allows the passage of other catheters inside its cylindrical body.
  • Some disadvantages are shown by the mesh pore size, whose range is defined in the range of about 1mm to about 0,1 mm, and by the absence of a distal closure mechanism that inherently would prevent upstream release of emboli at closure.
  • the filter has a proximal funnel that allows working catheters crossing a generally closed filter port, whilst preventing downstream collected emboli release; this allows the working catheters of accessories and / or transcatheter devices be tracked inside the filter without directly contacting the vessel after, contributing to prevent vessel wall injuries and relevant calcification detachment, whilst preventing emboli release.
  • the filter has a distal closure mechanism, to be used prior to retrieve the device preventing upstream emboli release at closure. Furthermore, protection of cerebral and peripheral circulation is guaranteed both for macroemboli and microemboli, thanks to adequate filter mesh pore selection.
  • a transcatheter intraprocedural filter prosthesis (1) for blood vessel comprising expandable (self-expandable) distal (9) and proximal (10) support structures, a tubular filter (2), an internal catheter (11), an external shaft (13), a handle (16) ( Fig. 1 , 1a ); said tubular filter (2) forming a tubular shape when deployed, with a distal end being normally open and a proximal port (7) normally closed.
  • the complete collapsing and deployment of the filter is enabled by the relative linear movement of the external shaft (13) respect to the internal supporting catheter (11).
  • the functional element (tubular filter 2 and supports 9, 10) and the delivery system (catheters 11 and 13, handle 16) can be permanently joined.
  • the distal end of the deployed filter (5) is positioned in ascending aorta (23), upstream respect to innominate artery (24), and the proximal end (6) is positioned in descending aorta (26), downstream respect to the end of aortic arch (25).
  • the funnel (4) configuration can be modified during the procedure by maintaining its apex downstream ( Fig. 4b ) or reverted inside the filter main body (3: Fig. 4a ) or in an intermediate position.
  • the device can be completely or partially collapsed during the procedure in order to be re-positioned.
  • both the distal and proximal closure mechanisms are activated ( Fig. 7b ), then the device is collapsed, retracted inside the shaft and fully retrieved out from the patient.
  • the filter device (1) is intended to be inserted prior to start other transcatheter procedures and to be retrieved after other transcatheter devices removal.
  • the filter device here described is adapted to guarantee an antiembolic protection ensuring navigation of other working catheters into the filter, permanent closure at the proximal end and closure at the distal end before filter retrieve, thus giving advantages respect to existing devices and methods.
  • the antiembolic filter device comprises the following macro elements ( Fig. 1 ): an assembly (12), which includes a tubular filter (2) adapted to retain emboli, whilst allowing blood flow, a structure assembly (8) to sustain the filter and make it couple with a vessel, an external shaft (13) to collapse / track / deploy / retrieve said assembly and a handle (16) to enable with specific commands said operations, together with the optimal sealing with the vessel and the interaction with other devices.
  • an assembly (12) which includes a tubular filter (2) adapted to retain emboli, whilst allowing blood flow, a structure assembly (8) to sustain the filter and make it couple with a vessel, an external shaft (13) to collapse / track / deploy / retrieve said assembly and a handle (16) to enable with specific commands said operations, together with the optimal sealing with the vessel and the interaction with other devices.
  • the tubular filter (2) is placed externally to the structure assembly (8), as shown in Fig. 1 : this assembly comprises a distal support structures (9), placed upstream respect to the blood flow direction and intended to make a leak-free coupling of the filter with the vessel, a proximal support structure (10), defining the region where the emboli are collected and where other devices pass inside the filter by crossing relevant port (7), and a supporting catheter (11), as shown in Fig. 1c .
  • said tubular filter (2), structure assembly (8), esternal shaft (13) and handle (16) are permanently joined.
  • said filter device is adapted to be used as an intra-aortic protection, extending from the ascending aorta (23), upstream with respect to the innominate artery (24), to the descending aorta (26).
  • Fig. 1a show the main components of said filter device (1) here below described starting from the filter (2) components, then going to the structure (8), shaft (13), handle (16).
  • the tubular filter (2) is made of a low friction porous and flexible polymeric or composite material, here including polyester or polyamide, with mesh pore preferably lower than 150 microns. It can be coated with either a hydrophilic, low friction or anti-thrombogenic coating or a combination of thereof. Filter material, coating and shape facilitate the navigation of transcatheter devices into its body, both during the insertion and the retrieval, preventing relevant direct contact with the vessel wall, that can make injuries on it. Specific embodiments comprise perforated membranes and fabrics.
  • a woven fabric can be chosen, with warp and weft either made by multifilament or monofilament yarn, with an either constant or variable weaving pattern, thus resulting in a pore comprised amongst the square and the circular geometry and either constant or variable mesh pore and open area along the filter longitudinal and circumferential directions.
  • the tubular filter (2) is geometrically defined by a distal element and a proximal element, namely a main body (3) and a funnel (4) ( Fig. 1a ).
  • the main body (3) comprises a distal end (5) and a proximal end (6); said distal end (5) is adapted to be open when the device is in active configuration, hermetically coupled with the vessel and closed before the device retraction; said proximal end (6) that is adapted to be open in the active configuration; said funnel (4) forming an extension of said main body (3), with the funnel base located at said proximal end (6).
  • Embodiments for the filter main body (3: Figlb) include a cylindrical body, a conical body and combination thereof.
  • Specific embodiments for intra-aortic procedures comprise a three regions main body (referred as 3e in Fig. 1b ), with a distal cylindrical part coupling with the aorta (3-1), an intermediate conical part (3-2) having a progressively decreasing diameter and a proximal cylindrical part (3-3), with: said intermediate part shaped to reduce relevant pressure drop for blood circulation and the overall filter encumbrance along the internal side of the aortic arch (25); said proximal cylindrical part geometry intended to allow free forward and back movement of working catheters, even in case of retrieve of partially recollapsed TAVIs in descending aorta.
  • the length of the main body is generally comprised from 10 to 30 cm, in order to be adapted to extend for all the vessel length to be protected from the ascending aorta (23), upstream with respect to the innominate artery (24), to the descending aorta (26).
  • Embodiments for the filter funnel (4) include movable and fixed funnels, with either symmetric or asymmetric shapes.
  • Fig.4 shows an embodiment of a movable funnel (4), with funnel in its extreme configurations: a first position (detailed in Fig 4b ), in which the funnel apex is proximal with respect to main body (3) proximal open end (6) and a second position (detailed in Fig 4a ), in which the funnel apex is positioned within said main body, between said main body (3) distal and proximal ends.
  • the funnel top is generally positioned inside the main body, thus acting as a sliding conveyor for working catheters that cross it, whilst gathering the emboli in the interspace amongst the main body and the funnel (referred as 4c), this making the interaction between the working catheter and the funnel port intrinsically free from emboli.
  • the funnel is oriented by acting on the apex, i.e. with a push-pull system commanded by the handle as detailed in Fig. 4b and 4a , this embodiment allowing to move the funnel also whilst a working catheter crosses it.
  • a second embodiment for the funnel comprises a fixed funnel element with distal apex (4-2), enabling the crossing of working catheters, joined to the following elements: laterally, to a fixed conical element, being the proximal part of the main body (2), with proximal apex (4-1) adapted to collect emboli; to a proximal ring (10, shaped as a "8"), that defines the base of the funnel and of the collecting conical element; to a flap (4-3), with distal end base either connected to the filter main body (2) or to the supporting catheter (11) and proximal end connected at least in a single point to the funnel 4-2, this flap adapted to prevent emboli release downstream, whilst allowing the funnel to be crossed.
  • the funnel in a third embodiment, it comprises an orientation fixed funnel element with the base open at the proximal end in the active configuration, acting as a conveyor; this funnel being joined to at least the following elements: laterally, to a fixed conical element, being the proximal part of the main body (2), with the apex closed at the proximal end; to a radially expandable proximal structure (10), said proximal structure either being manually activated or self-expandable.
  • the funnel element is generally positioned in a straight portion of the vessel, in order to ensure easy crossing of working catheters at its apex.
  • the funnel is shorter than main body, with a ratio of the funnel to main body length is generally comprised between 1/10 and 1/3, depending on the specific vessel centerline length, shape and vessel diameter.
  • Specific intra-aortic embodiments have a funnel length generally comprised between 2 and 10 cm.
  • the proximal closure system (14) preventing downstream emboli release, which is positioned at the funnel (4) apex is referred as the filter proximal port (7): it can either consists of a funnel geometry shaped in order to have the apex oriented downstream respect to the blood flow or consists of a folded top or a combination of thereof systems or consists of an actual closure system; an example of closure system is constructed by a lazoo system activated by a wire, either manually (14b) or automatically (14a), thanks to an elastic wire. Fig.
  • FIG. 7b shows examples of proximal port applied to a movable funnel systems: in the two pictures at the top, a mechanical closure mechanism is shown in the open (b1) and closed (b2) positions, whilst in the two pictures at the bottom two different self-sealing automatic closure embodiments are shown (a-a; a-b).
  • the distal closure system (15), used to prevent upstream dislodgement at the end of the procedure, is activated before recollapsing the device ( Fig 7a ), being either a lazoo system, manually activated, or an automatic elastic system, which is manually deactivated in the active configuration.
  • a specific embodiment of the support structure assembly (8) is shown in Fig. 1c ; it comprises at least: a supporting catheter (11) extending within the main body, one radially expandable distal structure (9) joined to said main body distal end, one radially expandable proximal structure (10) positioned at said main body proximal end level, said distal structure (9) and said proximal structure (10) being fixed to said supporting catheter (11).
  • Fig. 2 and Fig. 3 show two intra-aortic embodiments of the filter device (1) in the active configuration, differing on the distal structure (9) element.
  • the mechanical stability of the filter device is ensured at least by the coupling of the distal structure (9) with the ascending aorta vessel and by the coupling of the supporting catheter (11) with the aortic arch.
  • the radial expandable characteristics of the distal structure ensure to cover a broad range of geometry (with ascending aorta diameter usually ranging between 20 and 40 mm) and anatomies with a reduced number of sizes for the filter device without risk of device dislodgment or migration.
  • the distal (9) structure comprises two rings elements (9b: here referred as the more proximal and the more distal elements), mutually joined: the more distal ring element is joined to the catheter (11) at its distal end, to the more proximal ring element at its proximal end and to the distal end of the main body (2) along its perimeter; the more proximal element is connected at its proximal end to a specific handle sealing command by a rod, passing inside a lumen of the supporting catheter (11).
  • This structure can be either constructed of a single wire or multiple wires having either a circular, elliptical or rectangular section, or a combination thereof; the joinings amongst the components can be made by crimping, welding, gluing, binding or, in case of wire elements by twisting them, or with a combination of thereof methods.
  • the distal ring element is designed to radially expand conforming to the aorta in the active configuration, thus guaranteeing a leak-free coupling: this is ensured by the high elasticity limit of the material used, preferably but not exclusively being Nitinol, by its geometry, with perimeter larger than the aorta vessel, by relevant axis free orientation, tilted respect to aorta centerline and by relevant deformation mechanisms commanded by the handle.
  • the proximal ring element pushes onto the distal one, thus partially tilting relevant ring plane and resulting in radial compression onto the aortic wall.
  • the pulling handle command (backward movement on the command 16b: Fig 2b ) can be adopted in order to close the filter main body distal end without using specific commands.
  • the interconnection amongst distal ring and funnel commands can act simultaneously on the closure mechanism of the filter distal end and on the movement of the funnel apex, thus simplifying the handle mechanism and the operations to be carried out prior to the device retrieve.
  • the distal (9) structure comprises one ring element (9a), with proximal end joined to the catheter (11), perimeter joined at the distal end of the main body (2), distal end joined to a single or multiple wire passing inside the filter and connected to a specific handle sealing command.
  • the radial expansion of the ring ( Fig 3a ) is ensured by a pulling system rather than a pushing system command.
  • proximal structure (10) is shown in Fig. 4 , with structure shaped as a ring and connected to the supporting catheter.
  • the ring defines the base of the funnel (4), allowing to orient it either in the proximal and distal directions, by tilting its apex by specific commands connected to the handle.
  • the ring doesn't couple with the descending aorta.
  • the proximal structure (10) can be shaped similarly respect to the distal structure (9), thus allowing to radially couple with the aorta vessel.
  • Specific embodiments can be constructed wherein structures intermediate respect to the distal (9) and proximal (10) can be connected to the supporting catheter (11), in order to increase the device stability and contribute to fully expand the tubular filter main body.
  • the overall geometry can be elliptical in plan view, but also differently shaped as shown in Fig. 8 ; similarly, lateral view can show a planar structure but also a "S" shaped lateral profile to enhance leak-free conforming to the aortic arch, as shown in Fig. 8 .
  • the supporting catheter (11) which is joined to the distal (9) and proximal (10) structures and to the tubular filter (2), adapts in the active configuration at the extrados of the aortic arch and sustains all the loads arising from the procedure (see Fig. 11 ): at this purpose it can be made by a flexible polymeric or a composite material, here including a metal braided polymer, selected as the best compromise amongst high elongation / compression / torsion stiffness and fairly high flexibility.
  • the supporting catheter (11) profile is adapted to house inside specific lumens, the commands to crimp / deploy the filter (2), to act on the distal (9) and proximal (10) structures and on the distal and proximal filter closure system, where applicable, and to house other accessories / working catheters, here including guide-wire, pig-tail and balloon catheters, here contributing to simplify the overall procedure.
  • the external shaft (13: see details in Fig. 10 and 11 ) is adapted to guide the collapsed filter assembly (12) in position and to allow the deployment/recapture of the device, by sliding backward and forward respect to the multilumen catheter.
  • the external shaft (13) is made of a flexible polymeric or composite material and preferably a metal braided polymer, i.e with reduced tensile and compression elongation and with adequate flexural compliance to ensure optimal pushability when tracking the filter device along the aortic arch, thus allowing to adapt to the extrados curvature of aorta without forcing onto it and minimizing snacking whilst interacting with the supporting catheter to crimp / deploy the filter.
  • a tip (17) can be included in any of the said structures (9, 11) or external shaft (13) or other structures to allow adequate priming, easy crossing of the introducer and smooth navigation into the aorta ( Fig.2 and Fig.10 ).
  • Radiopaque markers (19: see details in Fig.10 , Fig.11b ) can be joined to specific locations (11, 13, 9, 10 or other structures) in order to facilitate, via adequate imaging, the positioning of the device (1) and of other working catheters intended to cross it.
  • the handle (16: Fig.1a ) allows specific commands including, where applicable, the sliding between an external shaft (13) and the supporting catheter (11), thus allowing filter crimping or deployment (16a), the activation of the distal closure mechanism (16e), the activation of proximal (14: 16d) and distal (15: 16e) closure mechanisms, the tensioning of the distal support structure (9: 16b), the funnel movement (16c), the flushing of the ports for guide wire (16f) and external shaft (16g), the direct loading of other devices or accessories, not limited to a guide wire and / or a pig tail catheter and the enabling / disabling of an artificial valve (18), where applicable.
  • the handle structure is made preferably but not exclusively by polymeric material; it houses all the commands, either made by rods or wires, and the proximal terminations of the supporting catheters (11) and of the external shaft (13), either directly or with the interposition of metal tubes.
  • the handle can adopt either linear / rotatory mechanism to allow said movements and block systems, where applicable, to fix it in a determined position.
  • transcatheter procedure adopting the antiembolic filter device (1) is detailed, with specific features referring to an intra-aortic procedure, here comprising a TAVI, which allow cerebral and systemic emboli protection.
  • the antiembolic filter device (1) access is made from the femoral artery opposite (secondary) to that one (main) accessed by the working catheter (31) used for the prosthesis or the device to treat the aortic valve ( Fig.11d ).
  • the working catheter (31) used for the prosthesis or the device to treat the aortic valve Fig.11d .
  • This method allows to deploy the filter device prior to the other working catheters (31: see Fig.11d ) and retrieve it after all the other working catheters, thus enabling to:

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
EP19167599.0A 2019-04-05 2019-04-05 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux Withdrawn EP3718505A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP19167599.0A EP3718505A1 (fr) 2019-04-05 2019-04-05 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux
CN202080027045.1A CN113660915B (zh) 2019-04-05 2020-04-03 动脉和静脉血管的经导管抗栓塞过滤器
CA3130859A CA3130859A1 (fr) 2019-04-05 2020-04-03 Filtre anti-embolique transcatheter pour vaisseaux arteriels et veineux
JP2021557526A JP7485383B2 (ja) 2019-04-05 2020-04-03 動脈および静脈用の経カテーテル塞栓防止フィルタ
US17/442,168 US12465477B2 (en) 2019-04-05 2020-04-03 Transcatheter anti embolic filter for arterial and venous vessels
PCT/EP2020/059601 WO2020201524A1 (fr) 2019-04-05 2020-04-03 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux
EP20720905.7A EP3946146B1 (fr) 2019-04-05 2020-04-03 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19167599.0A EP3718505A1 (fr) 2019-04-05 2019-04-05 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux

Publications (1)

Publication Number Publication Date
EP3718505A1 true EP3718505A1 (fr) 2020-10-07

Family

ID=66101957

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19167599.0A Withdrawn EP3718505A1 (fr) 2019-04-05 2019-04-05 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux
EP20720905.7A Active EP3946146B1 (fr) 2019-04-05 2020-04-03 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP20720905.7A Active EP3946146B1 (fr) 2019-04-05 2020-04-03 Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux

Country Status (6)

Country Link
US (1) US12465477B2 (fr)
EP (2) EP3718505A1 (fr)
JP (1) JP7485383B2 (fr)
CN (1) CN113660915B (fr)
CA (1) CA3130859A1 (fr)
WO (1) WO2020201524A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3403615A1 (fr) 2017-05-17 2018-11-21 Aorticlab Sarl Prothèse de valve transcathéter pour vaisseau sanguin
WO2019053538A1 (fr) 2017-09-12 2019-03-21 Aorticlab Sarl Dispositif transcathéter pour le traitement de feuillets de valves cardiaques calcifiés
EP3687443B1 (fr) 2017-09-28 2024-12-18 Zeev Brandeis Protection aortique
AU2019389001B2 (en) 2018-11-28 2025-08-14 Histosonics, Inc. Histotripsy systems and methods
EP3718505A1 (fr) 2019-04-05 2020-10-07 Aorticlab Sarl Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux
IL300851A (en) 2020-08-27 2023-04-01 Univ Michigan Regents Ultrasonic transducer with transmit-receive capability for focused ultrasound
CN116138923A (zh) * 2021-11-19 2023-05-23 上海蓝帆博奥医疗科技有限公司 血栓过滤装置
CN116138922A (zh) * 2021-11-19 2023-05-23 上海蓝帆博奥医疗科技有限公司 血栓过滤装置
CN113952074B (zh) * 2021-11-25 2025-03-07 苏州希尔医疗科技有限公司 一种栓子保护及收集装置
WO2023230298A1 (fr) * 2022-05-22 2023-11-30 Excision Medical, Inc. Système chirurgical de gestion de la circulation sanguine pendant une intervention chirurgicale
JP2025527698A (ja) * 2022-08-25 2025-08-22 ゼーヴ ブランデイス 体腔におけるデブリ保護デバイスの固定
AU2023366591A1 (en) 2022-10-28 2025-04-24 Histosonics, Inc. Histotripsy systems and methods
WO2024221001A2 (fr) 2023-04-20 2024-10-24 Histosonics, Inc. Systèmes d'histotripsie et procédés associés comprenant des interfaces utilisateur et des flux de travail pour la planification et la thérapie de traitement

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
WO2008066881A1 (fr) * 2006-11-29 2008-06-05 Amir Belson Dispositif de protection des embolies
AU2011202667A1 (en) 2003-12-23 2011-06-30 Sadra Medical, Inc. Apparatus and methods for heart valve replacement
US20130096606A1 (en) * 2011-10-17 2013-04-18 William C. Bruchman Embolic protection devices and related systems and methods
US20140005540A1 (en) 2011-01-07 2014-01-02 Innovative Cardiovascular Solutions, Inc. Angiography Catheter
US20140257362A1 (en) * 2013-03-07 2014-09-11 St. Jude Medical, Cardiology Division, Inc. Filtering and removing particulates from bloodstream
WO2015185870A1 (fr) 2014-06-05 2015-12-10 Bernard Pain Dispositif d'introduction transcatheter dans la racine aortique au niveau de la jonction sino tubulaire
US20160235515A1 (en) 2013-10-21 2016-08-18 Innovative Cardiovascular Solutions, Llc Embolic Protection Device
WO2017042808A1 (fr) 2015-09-07 2017-03-16 Filterlex Medical Ltd. Dispositif de filtre de protection contre une embolie intra-aortique
US20170181835A1 (en) * 2015-12-29 2017-06-29 Emboline, Inc. Multi-access intraprocedural embolic protection device
US20180110607A1 (en) 2012-01-06 2018-04-26 Emboline, Inc. Introducer sheath with embolic protection
US20180177582A1 (en) 2009-01-16 2018-06-28 Claret Medical, Inc. Intravascular blood filter
WO2018211344A1 (fr) 2017-05-17 2018-11-22 Aorticlab Sàrl Prothèse valvulaire transcathéter pour vaisseau sanguin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2361670C (fr) 1999-01-27 2010-03-30 Viacor Incorporated Procedes et dispositifs pour interventions sur valvules cardiaques
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
DE10191982T1 (de) 2000-06-23 2003-11-06 Salviac Ltd Filterelement für Embolieschutzgerät
WO2002047539A2 (fr) 2000-12-15 2002-06-20 Viacor, Inc. Dispositif et methode pour remplacement de la valvule aortique
CA2472374C (fr) 2001-12-05 2012-02-14 Sagax, Inc. Dispositif endovasculaire d'enclavement d'une matiere particulaire et sa methode d'utilisation
WO2004019817A1 (fr) 2002-08-27 2004-03-11 Amir Belson Dispositif de protection embolique
US20060287668A1 (en) 2005-06-16 2006-12-21 Fawzi Natalie V Apparatus and methods for intravascular embolic protection
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
WO2008097556A1 (fr) 2007-02-05 2008-08-14 Boston Scientific Limited Systèmes et procédés d'implantation de valvule
EP2120737B1 (fr) * 2007-02-05 2020-04-01 Boston Scientific Limited Appareil de thrombectomie
EP2603172A4 (fr) 2010-08-09 2014-10-22 Valvexchange Inc Valve de retenue sous-valvulaire temporaire
EP2522307B1 (fr) 2011-05-08 2020-09-30 ITSO Medical AB Dispositif pour la mise en place de dispositifs médicaux dans une valvule cardiaque
WO2014059005A1 (fr) 2012-10-09 2014-04-17 Boston Scientific Scimed, Inc. Dispositif de protection contre l'embolie aortique à ouverture spéciale pour interventions cardiaques structurales
EP2948104B1 (fr) 2013-01-25 2019-07-24 Apica Cardiovascular Limited Systèmes pour accès percutané, stabilisation et fermeture d'organes
MX2015012914A (es) 2013-03-13 2016-04-04 Bunker Energy Partners Llc Sistemas y metodos para generar energia utilizando un ciclo de hidrogeno.
US9986967B2 (en) 2013-03-15 2018-06-05 Volcano Corporation Distal protection systems and methods with pressure and ultrasound features
WO2015184450A1 (fr) 2014-05-30 2015-12-03 Cardiac Valve Solutions Llc Valve temporaire et filtre sur cathéter de guidage
FR3021860A1 (fr) 2014-06-05 2015-12-11 Bernard Pain Dispositif transcatheter pour l'ablation de tissus calcifies au niveau des volets d'une valve aortique
WO2019053538A1 (fr) 2017-09-12 2019-03-21 Aorticlab Sarl Dispositif transcathéter pour le traitement de feuillets de valves cardiaques calcifiés
EP3685772A1 (fr) 2019-01-24 2020-07-29 Aorticlab Sarl Dispositif pour le traitement de la calcification tissulaire
EP3718505A1 (fr) 2019-04-05 2020-10-07 Aorticlab Sarl Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
AU2011202667A1 (en) 2003-12-23 2011-06-30 Sadra Medical, Inc. Apparatus and methods for heart valve replacement
WO2008066881A1 (fr) * 2006-11-29 2008-06-05 Amir Belson Dispositif de protection des embolies
US20180177582A1 (en) 2009-01-16 2018-06-28 Claret Medical, Inc. Intravascular blood filter
US20140005540A1 (en) 2011-01-07 2014-01-02 Innovative Cardiovascular Solutions, Inc. Angiography Catheter
US20130096606A1 (en) * 2011-10-17 2013-04-18 William C. Bruchman Embolic protection devices and related systems and methods
US20180110607A1 (en) 2012-01-06 2018-04-26 Emboline, Inc. Introducer sheath with embolic protection
US20140257362A1 (en) * 2013-03-07 2014-09-11 St. Jude Medical, Cardiology Division, Inc. Filtering and removing particulates from bloodstream
US20160235515A1 (en) 2013-10-21 2016-08-18 Innovative Cardiovascular Solutions, Llc Embolic Protection Device
WO2015185870A1 (fr) 2014-06-05 2015-12-10 Bernard Pain Dispositif d'introduction transcatheter dans la racine aortique au niveau de la jonction sino tubulaire
WO2017042808A1 (fr) 2015-09-07 2017-03-16 Filterlex Medical Ltd. Dispositif de filtre de protection contre une embolie intra-aortique
US20170181835A1 (en) * 2015-12-29 2017-06-29 Emboline, Inc. Multi-access intraprocedural embolic protection device
WO2018211344A1 (fr) 2017-05-17 2018-11-22 Aorticlab Sàrl Prothèse valvulaire transcathéter pour vaisseau sanguin

Also Published As

Publication number Publication date
CN113660915B (zh) 2025-10-21
CA3130859A1 (fr) 2020-10-08
US20220168087A1 (en) 2022-06-02
EP3946146B1 (fr) 2024-06-05
EP3946146A1 (fr) 2022-02-09
EP3946146C0 (fr) 2024-06-05
WO2020201524A1 (fr) 2020-10-08
JP7485383B2 (ja) 2024-05-16
JP2022526955A (ja) 2022-05-27
CN113660915A (zh) 2021-11-16
US12465477B2 (en) 2025-11-11

Similar Documents

Publication Publication Date Title
EP3946146B1 (fr) Filtre anti-embolique transcathéter pour vaisseaux artériels et veineux
US20230047943A1 (en) Vascular filters, deflectors, and methods
US10881496B2 (en) Embolic protection during percutaneous heart valve replacement and similar procedures
EP3624732B1 (fr) Prothèse de valve transcathéter pour vaisseau sanguin
US12097108B2 (en) Systems and methods for protecting the cerebral vasculature
KR102094046B1 (ko) 혈관조영 카테터
WO2013082555A1 (fr) Dispositif de protection embolique et son procédé d'utilisation
JP2010512231A (ja) 血液中の物質を頭部を避けるように物理的にそらすための埋め込み、システムおよび方法
US11351023B2 (en) Systems and methods for protecting the cerebral vasculature
US20240366357A1 (en) Systems and methods for protecting the cerebral vasculature

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210408